(Q50940908)

25 March 2018

title

Developmental patterns of serum 3 alpha-androstanediol glucuronide. (English)

1 reference

25 March 2018

8

W Kiess

1 reference

25 March 2018

H L Rittner

1

1 reference

25 March 2018

P D Lee

2

1 reference

25 March 2018

W F Blum

3

1 reference

25 March 2018

H G Doerr

4

1 reference

25 March 2018

J Steiss

5

1 reference

25 March 2018

J Kreuder

6

1 reference

25 March 2018

W Rascher

7

1 reference

25 March 2018

publication date

1 May 1997

1 reference

25 March 2018

Journal of Endocrinological Investigation

published in

1 reference

25 March 2018

volume

20

1 reference

25 March 2018

issue

5

1 reference

25 March 2018

page(s)

245-250

1 reference

25 March 2018

Origin of plasma androstanediol glucuronide in men

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03350295

Physiopathology of plasma androstanediol-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350295

5 alpha-androstane-3 alpha, 17 beta-diol and 5 alpha-androstane-3 alpha, 17 beta-diol-glucuronide in plasma of normal children, adults and patients with idiopathic hirsutism: a mass spectrometric study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350295

3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350295

Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03350295

Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women

21 January 2018

1 reference

12 December 2020

Serum 3 alpha-androstanediol glucuronide measurements in sexually mature women with congenital adrenal hyperplasia during therapy

1 reference

12 December 2020

17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia

1 reference

12 December 2020

Measurements of 3 alpha,17 beta-androstanediol glucuronide in serum and urine and the correlation with skin 5 alpha-reductase activity

1 reference

12 December 2020

Reference values for androstanediol glucuronide

1 reference

12 December 2020

Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia

1 reference

12 December 2020

3α-Androstanediol Glucuronide in Premature and Normal Pubarche*

1 reference

12 December 2020

Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels

1 reference

12 December 2020

Plasma 3 alpha-androstanediol glucuronide in precocious adrenarche

1 reference

12 December 2020

Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men

1 reference

12 December 2020

The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women**Supported in part by National Institutes of Health grant HD-17519-01A1

1 reference

12 December 2020

3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion

1 reference

12 December 2020

Androgen conjugates: physiology and clinical significance

1 reference

12 December 2020

Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03350295

1 reference

25 March 2018

1 reference

25 March 2018